ESC Premium Access

Antithrombotic treatment and valve-related outcomes (GALILEO 4D, ATLANTIS 4D): do they matter .

Presentation

3 more presentations in this session

Antithrombotic treatment after TAVI in patients without indication for anticoagulation: anything else than aspirin.

Thumbnail

Antithrombotic treatment after TAVI in patients with indication for anticoagulation.

Thumbnail

Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .

Thumbnail

Access the full session

Antithrombotic therapy after TAVI

Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

This platform is supported by

logo Novo Nordisk